Product Code: 26EL-604-4035
Please note: This is a Single Viewer registration for one participant for the on-demand version of this program. Access instructions for the on-demand version of this program will be provided via email approximately 3-10 business days after the live program has occurred and the on-demand version is available. If registering after the on-demand version is available, immediate access is granted via the AABB Education Platform at https://education.aabb.org.
If you registered for the live program you do not need to register for this on-demand eCast (access to the on-demand eCast was included with the live program registration).
If you are interested in presenting this program to a group, please see the “eCast Registration Form– Group Viewing” form on the program page.
Program Description: Pediatric transfusion medicine presents distinct challenges that differ from adult practice. Neonates and children undergo dynamic developmental changes in their physiology and hemostatic systems that can vary significantly based on age and clinical condition. These developmental differences necessitate specialized knowledge and careful consideration of transfusion-related risks and requirements to ensure safe and effective therapy. Adverse events may be underrecognized in pediatric patients, and certain complications, such as hyperkalemia, patient identification errors, or excessive or over-rapid transfusion, occur more frequently in young children. Despite growing pediatric-specific evidence, transfusion practices in neonatal and pediatric patients remain highly variable across institutions.
Through case-based clinical vignettes interwoven into a lecture format, this program will cover the clinical indications for transfusion of major blood components, review current evidence from key clinical trials informing transfusion threshold guidelines, and examine the spectrum and management of transfusion-related adverse events in neonatal and pediatric patients. The program will also introduce the concept of individualized transfusion decisions using non-invasive monitoring tools as an adjunct to hemoglobin levels. By bridging the gap between limited pediatric-specific evidence and clinical practice, this program aims to help participants identify strategies and apply emerging data to optimize transfusion practices in neonatal and pediatric patient care.
